American Dental Laser/Sunrise Technologies
This article was originally published in The Gray Sheet
Executive Summary
Settle dispute over manufacturing and distribution rights to dental lasers by terminating Sunrise's exclusive rights to manufacture lasers for ADL and reaffirming ADL's ownership of dental laser patents, according to a Feb. 5 ADL press release. Sunrise will no longer have the right of first refusal to develop new products for ADL but will obtain a license to use ADL's dental patents. Sunrise also has agreed to supply ADL with three-watt dental lasers worldwide and eight-watt dental lasers in the U.S. and Japan until February 1994. The two companies submitted a dispute to binding arbitration in April over contracts respecting the dLase 300 three-watt laser system that Sunrise manufacturers for ADL ("The Gray Sheet" April 27, I&W-1).
You may also be interested in...
Executives On The Move: Changes At The Top At Enzolytics, Dyne Therapeutics And Seres Therapeutics
Recent moves in the industry include new chief financial officers at LENZ Therapeutics and Botanix Pharmaceuticals, plus new chief medical officers at Vigil Neuroscience and Voyager Therapeutics.
Israel's Gamida Cell Survives By Selling To Lender
Having finally secured US approval for Omisirge, Gamida was hoping to bag a strategic partner for the cell therapy. A year on, no suitable partner has been identified and the firm is delisting from the NASDAQ and going private.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.